Endothelium-dependent vasodilation by ferulic acid in aorta from chronic renal hypertensive rats  by Choi, Seok et al.
Kidney Res Clin Pract 31 (2012) 227–233journal homepage: http://www.krcp-ksn.com
Kidney Research and Clinical Practice2211-9
ND lice
http://
n Corre
Chosun
Korea.
E-mailContents lists available at ScienceDirectOriginal ArticleEndothelium-dependent vasodilation by ferulic acid in aorta
from chronic renal hypertensive ratsSeok Choi 1, Hyun Il Kim2, Sang Hag Park 2, Mi Jung Lee 1, Jae Yeoul Jun 1,
Hyun Lee Kim3, Jong Hoon Chung 3, Cheol Ho Yeum1,n
1 Department of Physiology, College of Medicine, Chosun University, Gwangju, Korea
2 Department of Psychiatry, College of Medicine, Chosun University, Gwangju, Korea
3 Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, KoreaArticle history:
Received 29 May 2012
Received in revised form
6 July 2012
Accepted 30 July 2012
Available online 21 September 2012
Keywords:
Endothelium
Ferulic acid
Renal hypertension
Vasodilation132/$ - see front matter & 2012. The Ko
nse (http://creativecommons.org/licen
dx.doi.org/10.1016/j.krcp.2012.09.001
sponding author. Department of Physio
University, 309, Pilmun-daero, Don
address: chyum@chosun.ac.kr (CH YeumA b s t r a c t
Background: Ferulic acid (FA) is a naturally occurring nutritional compound.
Although it has been shown to have antihypertensive effects, its effects on vascular
function have not been intensively established. The aim of this study was to assess the
vasoreactivity of FA in chronic two-kidney, one-clip (2K1C) renal hypertensive rats.
Methods: Hypertension was induced in 2K1C rats by clipping the left renal artery and
age-matched rats that received a sham treatment served as a control. Thoracic aortas
were mounted in tissue baths to measure isometric tension. The effects of FA on
vasodilatory responses were evaluated based on contractile responses induced by
phenylephrine in the aortic rings obtained from both 2K1C and sham rats. Basal nitric
oxide (NO) bioavailability in the aorta was determined by the contractile response
induced by NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME).
Results: FA induced concentration-dependent relaxation responses which were
greater in 2K1C hypertensive rats than in sham-clipped control rats. This relaxation
induced by FA was partially blocked by the removal of endothelium or by pretreating
with L-NAME. L-NAME-induced contractile responses were augmented by FA in
2K1C rats, while no signiﬁcant differences were noted in sham rats. FA improved
acetylcholine-induced endothelium-dependent vasodilation in 2K1C rats, but not in
sham rats. The simultaneous addition of hydroxyhydroquinone signiﬁcantly inhibited
the increase in acetylcholine-induced vasodilation by FA.
Conclusion: These results suggest that FA restores endothelial function by altering
the bioavailability of NO in 2K1C hypertensive rats. The results explain, in part, the
mechanism underlying the vascular effects of FA in chronic renal hypertension.
& 2012. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).rean Society of Nephrology. P
ses/by-nc-nd/4.0/).
logy, College of Medicine,
g-gu, Gwangju 501-759,
).Introduction
Ferulic acid (FA; 4-hydroxy-3-methoxycinnamic acid) is an
ubiquitous phenolic compound found in plant tissues and thus
is a bioactive ingredient in many foods. Some of the rich sources
of FA are rice bran, whole grain food, citrus fruits, banana,
beetroot, cabbage, spinach, and broccoli [1]. Several studies haveublished by Elsevier. This is an open access article under the CC BY-NC-
S Choi et al / Endothelium-dependent vasodilation228indicated that FA has antioxidant effects, antitumor activity, as
well as antihyperlipidemic and radioprotective properties [2–4].
Observational epidemiologic studies have shown that dietary
consumption of fruits and vegetables is associated with a lower
incidence of cardiovascular diseases and mortality resulting
from such diseases [5]. It has been previously demonstrated
that FA has an antihypertensive action when intravenously
administered in spontaneously hypertensive rats and that the
blood pressure lowering effect of FA is blocked by pretreatment
with a nitric oxide synthase (NOS) inhibitor [6], which suggests
that an NO-dependent vascular response is involved in this
mechanism. Increasing evidence suggests that FA restores
endothelial function by enhancing the bioavailability of basal
and stimulated NO in the aortas of hypertensive rats [7].
The endothelium plays a pivotal role in the maintenance of
vascular tone and blood pressure by regulating the release of
several vasoactive substances, including NO [8]. Functional
changes to the endothelium in various pathological conditions
are characterized by impaired endothelium-dependent relaxa-
tion. A deﬁcient production of endothelium-derived NO results
in diminished vasodilator tone, allowing vascular resistance to
increase, thereby contributing to the elevated blood pressure
levels [9–11]. Therefore, an altered role of NO may be critical in
the pathogenesis of hypertension. Indeed, the endothelium-
dependent vasodilation is impaired in a number of experimental
models, including two-kidney, one-clip (2K1C) renovascular,
aortic coarctation, Dahl salt-sensitive, deoxycorticosterone
acetate-salt, spontaneously hypertensive rats [10–13]. We have
also observed that the endothelium plays an inhibitory role in
the aortic contractions of rat by releasing NO, while its role is
altered in 2K1C hypertensive rats [14]. Although an improved
endothelium-dependent vasodilation by FA has been demon-
strated in the aortas of genetically hypertensive rats [7], the
effects of FA on vascular function in 2K1C hypertension remain
unclear.
This study was designed to examine the effects of FA on
the involvement of NO and endothelium-dependent and
endothelium-independent vasoreactivity in chronic 2K1C
renal hypertensive rats. The thoracic aorta of such rats was
isolated and the changes in isometric tension were recorded.Methods
Development of 2K1C hypertension
Male Sprague-Dawley rats, weighing 160–180 g, were
anesthetized with intraperitoneal injections of thiopental
sodium (40 mg/kg). An incision was made on the left ﬂank
to provide access to the left renal artery, which was separated
from the renal vein and was cleared of the connective tissues.
A U-shaped solid silver clip with an open gape of 0.2 mm was
inserted in the exposed renal artery, resulting in partial
occlusion of renal perfusion. The contralateral kidney was
left untouched and the wound was closed. A group of age-
matched rats received a sham treatment and they were
operated like 2K1C rats, except that no clip was inserted. All
animals were fed normal chow and given tap water. The rats
were tested 10 weeks after the clipping, because the endothe-
lial dysfunction is associated with the duration of hyperten-
sion [15]. Hypertensive rats were selected by measuring
systolic blood pressure in a conscious state using the tail-
cuff method.Tissue preparation
The thoracic aorta between the aortic arch and the diaphragm
was rapidly excised, cleared of adherent connective tissues, and
cut into rings (2–3mm in length) under a dissection microscope.
In some preparations, the endothelium was removed by gently
rubbing the intimal surface with a moistened cotton swab.
Successful removal of endothelial cells from aortic rings was
conﬁrmed by the inability of acetylcholine to induce relaxation.
The rings were mounted using two triangle-shaped stainless
steel holders in the vessel lumen in organ baths containing 15mL
of physiological salt solution (PSS) of the following composition
(in mM): NaCl, 118.3; KCl, 4.7; NaHCO3, 25; MgCl2, 1.2; KH2PO4,
1.2; CaCl2, 2.5; and glucose, 11.1 at 37 1C. The solution was
bubbled with a mixture of 95% O2 and 5% CO2. One of the holders
was ﬁxed at the bottom of the chambers and the other was
connected to a force displacement transducer (Grass FTO3) in
order to measure the isometric tension. Before initiating speciﬁc
experimental protocols, the aortic rings were equilibrated under
a resting tension of 2 g for at least 90 minutes. During this period,
the incubation medium was changed every 15minutes.
Protocols
In the ﬁrst set of experiments, to conﬁrm the vasorelaxant
activity of FA, the aortic rings from 2K1C and sham rats were
precontracted to 50% effective concentration with phenylephr-
ine (3107 M in sham and 4108 M in 2K1C rats), the
concentrations of which were obtained in preliminary experi-
ments. When the contractile response achieved a steady state,
we determined the concentration–response curves with respect
to the cumulative addition of FA (105–103 M) in aortic rings
with or without a functional endothelium. To verify the parti-
cipation of endothelium-derived products in the relaxant effects
of FA, experiments were performed in the presence of NG-nitro-
L-arginine methyl ester (L-NAME, 104 M), a nonselective NOS
inhibitor; indomethacin (105 M), a nonselective cyclooxygen-
ase inhibitor; thapsigargin (105 M), a sarco/endoplasmic reti-
culum Ca2þ-ATPase (SERCA) inhibitor, all of which were added
to the bath 20 minutes before the addition of phenylephrine.
In the second set of experiments, after an incubation period
of 45 min in 25 mM KCl (obtained by equimolar replacement of
NaCl by KCl in PSS), aortic rings with intact endothelium from
2K1C and sham rats were treated with L-NAME (10–4 M). The
contraction in the rings from rats that had been pretreated with
FA (105–103 M) for 30 minutes was measured. The resulting
contraction as a percent change of the 25 mM KCl was taken as
a measure of the basal bioavailability of NO [7,16].
In the third set of experiments, relaxation responses to
acetylcholine (109–105 M) were performed in the presence
or absence of L-NAME (104 M) in the aortic rings with
endothelium that were precontracted with phenylephrine.
In addition, the aorta was pretreated for 30 minutes with FA
(104 M) before the addition of phenylephrine. Acetylcholine
was then added and the resulting relaxation was taken as a
measure of the stimulating bioavailability of NO [7]. In an
alternate set of experiments, preparation of an aortic ring
involved mechanical removal of the functional endothelium
and pretreatment with FA (104 M) for 30 minutes before the
addition of phenylephrine. Endothelium-independent vasodi-
lation was induced by treating the rings from 2K1C rats with
sodium nitroprusside (SNP; 1010–106.5 M) and 3-morpho-
linosydnonimine (SIN-1; 1010–106.5 M). SNP has been used
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Figure 1. Ferulic acid (FA)-induced vasorelaxation in phenylephr-
ine-precontracted aortic rings from sham-clipped control and 2K1C
hypertensive rats. Points represent the means7SE with the number
(n) of experiments carried out in parentheses. * Po0.05, compared
with sham values.
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Kidney Res Clin Pract 31 (2012) 227–233 229as an NO donor and SIN-1 is known to release both NO and
superoxide anions (O2
) [17]. Superoxide dismutase (SOD,
150 U/mL) was added 5 minutes before the addition of phe-
nylephrine in the case of treatment with SIN-1.
In the fourth set of experiments, aortic rings with endothe-
lium from 2K1C rats were treated with FA (104 M) for
30 minutes before the addition of phenylephrine. Hydroxyhy-
droquinone (HHQ, 107 M), a generator of O2
 [18], was
added, followed by contraction with phenylephrine after
5 minutes, and the extent of vasodilation induced by acet-
ylcholine (4108 M) was measured. SOD (150 U/mL) or
catalase (1000 U/mL) was added 5 minutes before the addi-
tion of HHQ.
Drugs
The drugs used in the experiments were FA, L-NAME,
phenylephrine, acetylcholine, indomethacin, thapsigargin,
SNP, SIN-1, SOD, HHQ, and catalase. HHQ was purchased from
Wako Pure Chemical Industries, Ltd (Osaka) and the other
chemicals were from Sigma Chemical Co. (St. Louis, MO). FA
and indomethacin were dissolved in dimethylsulfoxide
(DMSO) and the others were prepared by dissolving in
distilled water. The ﬁnal bath concentrations of DMSO were
less than 0.05%, which did not alter the contraction or
relaxation responses.
Statistical analysis
Values presented in the ﬁgures are expressed as means and
standard error of the means. Relaxant responses are given as
the percent change in phenylephrine-induced precontraction.
Statistical comparisons were performed using the Student t
test or analysis of variance followed by Duncan’s test for
multiple comparisons. A P value o0.05 was considered to be
statistically signiﬁcant.FA  (-log M)
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Figure 2. Ferulic acid (FA)-induced vasorelaxation in phenylephr-
ine-precontracted aortic rings without endothelium (Endo) from
2K1C hypertensive rats. The results obtained by treatment with NG-
nitro-L-arginine methyl ester (L-NAME) are also shown. n, y Po0.05,
compared with control values, respectively.Results
Ten weeks after the operative intervention, systolic blood
pressures were 19374mmHg (n¼43, Po0.05) and 1387
5mmHg (n¼36) in 2K1C hypertensive and sham-clipped control
rats, respectively.
Vasorelaxant responses to FA
The tension induced by phenylephrine was enhanced in the
aortic rings from 2K1C rats (1.3870.09 g, Po0.05) than in
those from sham rats (1.0570.08 g). In the aortic rings from
2K1C rats, the addition of FA relaxed phenylephrine-induced
contraction in a concentration-dependent manner. Relaxation
was also induced in sham rats, but the degree was signiﬁcantly
lower than that for the 2K1C aortic rings (Fig. 1). The relaxation
induced by FA was markedly inhibited by removing the
endothelium or by pretreating the aorta with L-NAME in 2K1C
rats (Fig. 2). Treatment with indomethacin or thapsigargin did
not affect FA-induced vasorelaxation (data not shown).
Effect of FA on L-NAME-induced contraction
The magnitude of 25 mM KCl-induced contraction was
comparable between the aortic rings from 2K1C (342747 mg,n¼19) and sham rats (327733 mg, n¼22). When L-NAME was
added to the rings with 25 mM KCl, the resulting contraction
was greater in sham rats (375722%, Po0.05, n¼6) compared
with that in 2K1C rats (185719%, n¼5). In addition, the
contraction in rings from 2K1C rats that had been treated with
FA (104 or 103 M) was signiﬁcantly greater than the values
for those with vehicle-treated aorta, while no signiﬁcant differ-
ences were shown in sham rats (Fig. 3).
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Figure 3. Effects of ferulic acid (FA) on NG-nitro-L-arginine methyl
ester (L-NAME)-induced contraction in aortic rings from (A) sham-
clipped control and (B) 2K1C hypertensive rats. Contractile responses
to L-NAME were obtained in rings submaximally precontracted with
KCl (25 mM). The data presented were obtained from ﬁve to eight
experiments. n Po0.05, compared with the vehicle value.
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Figure 4. Effects of ferulic acid (FA) on vasodilatory responses
induced by acetylcholine in aortic rings with endothelium from
sham-clipped control and 2K1C hypertensive rats. * Po0.05, com-
pared with corresponding sham values. y Po0.05, compared with
corresponding 2K1C values.
S Choi et al / Endothelium-dependent vasodilation230Acetylcholine-induced or NO donor-induced vasodilation
Acetylcholine-induced vasodilation was signiﬁcantly atte-
nuated in aortic rings from 2K1C rats compared with those
from sham rats. Treatment with L-NAME (104 M) completely
inhibited the acetylcholine-induced vasodilatory effect in
both 2K1C and sham groups (data not shown). FA (104 M)
had no effect on the acetylcholine-induced vasodilation in
sham rats, while it signiﬁcantly potentiated the acetylcholine-
induced vascular response in aortic rings from 2K1C rats
(Fig. 4). In the aortic rings without endothelium from 2K1C
rats that had been precontracted with phenylephrine, SNP orSIN-1 produced a concentration-dependent vasodilation. FA
had no effect on SNP-induced vasodilation. FA also did not
affect SIN-1-induced vasodilation, while SOD enhanced the
vasodilatory effect of SIN-1 (Fig. 5).
Effect of HHQ on acetylcholine-induced vasodilation
HHQ (107 M) alone had no effect on the phenylephrine-
induced contraction in aortic rings with endothelium from
2K1C rats. FA augmented acetylcholine-induced vasodilation,
and HHQ inhibited the FA-induced improvement in acetyl-
choline reactivity. The effect of FA on acetylcholine-induced
vasodilation in the presence of HHQ was recovered by the
addition of SOD, while the addition of catalase did not affect
acetylcholine-induced vasorelaxation (Fig. 6).Discussion
It has been shown previously that vascular reactivity to
contractile agonist is enhanced in disease states such as hyper-
tension [19]. In accordance with our previous ﬁndings [14], the
contractile response to phenylephrine was augmented in 2K1C
hypertensive rats as compared with sham-clipped control rats.
In this study, FA caused a relaxation in phenylephrine-
precontracted aortic ring preparations with an intact endothe-
lium isolated from 2K1C rats, whereas the relaxant effect of FA
was negligible in sham rats. Similar results have also been
obtained in spontaneously hypertensive rats [7]. The FA-induced
endothelium-dependent relaxation was signiﬁcantly inhibited
by L-NAME, whereas the blocking of cyclooxygenase activity by
indomethacin or SERCA activity by thapsigargin had no effects
on the relaxation in aortic rings from 2K1C rats. These results
suggest that FA-evoked relaxation is NO dependent.
In order to examine whether the basal bioavailability of NO is
altered by FA in hypertension, L-NAME was added in aortic rings
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Figure 5. Effects of ferulic acid (FA) on vasodilatory responses induced
by (A) sodium nitroprusside (SNP) or (B) 3-morpholinosydnonimine
(SIN-1) in aortic rings without endothelium from 2K1C hypertensive
rats. The results obtained by pretreatment with superoxide dismutase
(SOD) are also shown. n Po0.05, compared with control values.
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Figure 6. Effects of hydroxyhydroquinone (HHQ) on vasodilatory
responses induced by acetylcholine in aortic rings with endothe-
lium from 2K1C hypertensive rats. The effects of HHQ on the ferulic
acid (FA)-induced enhancement in the acetylcholine-stimulated vaso-
dilatory response after pretreatment with superoxide dismutase (SOD)
or catalase are also shown. Data are attained from ﬁve to eight
experiments. n Po0.05, compared with the vehicle-treated value.
Kidney Res Clin Pract 31 (2012) 227–233 231with intact endothelium, which were precontracted with
25 mM KCl [16,20]. L-NAME-induced contractions were attenu-
ated in 2K1C rats as compared with sham rats. In agreement
with these observations, it has been demonstrated that the basal
release of NO is less pronounced in the resistance and conduit
arteries of hypertensive rats when compared with normotensive
rats [16,21]. We have also shown previously that the contractile
response to No-nitro-L-arginine, another NOS inhibitor, is
impaired in KCl-precontracted aortic rings from 2K1C rats as
compared with those from sham rats [20]. Furthermore, the
magnitude of L-NAME-induced contractions in rings from
2K1C rats that had been treated with FA was signiﬁcantly
enhanced than that for the vehicle-treated aorta. The resultsdemonstrate that FA increases basal NO bioavailability in the
L-NAME-induced contractile response in 2K1C hypertensive
rats, as has been shown previously in genetically hypertensive
rats [7]. These ﬁndings suggest that the vasorelaxant effect of
FA on phenylephrine-induced contractions is partially
mediated by endothelial NO in aortic rings from 2K1C rats.
By contrast, the FA-induced relaxation persisted even after
the removal of the intact endothelium or treatment with L-
NAME. Therefore, the possibility of FA having a direct effect
on vascular smooth muscle cells in addition to its effects on
endothelial cells cannot be ruled out.
The present study conﬁrmed earlier observations [13,14,22]
that endothelium-dependent relaxations to acetylcholine are
markedly depressed in 2K1C hypertensive rats as compared
with sham-clipped control rats. Treatment with L-NAME
completely inhibited the acetylcholine-induced vasodilatory
effect in both groups, suggesting that the acetylcholine-
induced vasodilation is largely due to NOS-derived NO. FA
potentiated the acetylcholine-induced vasorelaxation in aor-
tic rings from 2K1C rats, while it did not have any effect in
sham rats. Acetylcholine causes NO release by the activation
of speciﬁc endothelial receptors, resulting in the activation of
endothelial NOS [23]. Therefore, the results imply that
FA may stimulate the release of NO in this experimental
condition in 2K1C hypertensive rats. In association with these
observations, it has been suggested that FA enhances the
stimulating bioavailability of NO in aortic rings from
S Choi et al / Endothelium-dependent vasodilation232spontaneous hypertensive rats [7]. In addition, in the experi-
ment using an NO donor in aortic rings without endothelium
from 2K1C rats, FA had no effect on SNP-induced endothe-
lium-independent vasodilation. In this case, the results sug-
gest that FA does not affect the NO-dependent pathway in
vascular smooth muscle in 2K1C hypertensive rats.
Impaired endothelium-mediated vasodilation in hyperten-
sion has been linked to reduced NO bioavailability. This may
be secondary to decreased NO synthesis or to increased NO
degradation because of its interaction with O2
 [24]. It has
been demonstrated that NO can be scavenged by O2
– to form
peroxynitrite [24,25], effectively reducing endothelium-
derived NO. Indeed, it has been observed that O2
 generation
is increased in hypertension [26,27]. The report that FA
scavenges O2
– derived from xanthine and xanthine oxidase
[28] led us to hypothesize that the scavenging ability of FA
might explain the improvement in NO bioavailability in aortic
rings from 2K1C rats. To investigate this issue, the effects of
FA on the SIN-1-induced vasodilation were examined,
because SIN-1 is known to release both NO and O2
– [17].
Contrary to our expectations, FA failed to augment SIN-1-
induced endothelium-independent vasodilation, whereas SOD
potentiated the SIN-1-induced vasorelaxation. Based on these
ﬁndings, it appears unlikely that FA scavenges O2
 derived
from SIN-1 in this experimental condition.
The major ﬁnding from this study is that the L-NAME-
induced vasoconstrictions and the acetylcholine-induced
endothelium-dependent vasorelaxations are augmented by
FA in aortic rings from 2K1C hypertensive rats, while FA has
no effect in sham-clipped control rats. These results suggest
that FA may alter the bioavailability of NO in the vascular
endothelium in 2K1C rats, as had been shown previously in
spontaneously hypertensive rats. The issue of how NO bioa-
vailability is stimulated by FA in endothelial cells is unclear
based on the ﬁndings of this study. The vascular effects
induced by FA in 2K1C hypertensive rats should not be
assumed to reﬂect the increase in NO production in the
endothelium, because the NO system is overactive in hyper-
tension [10]. Several studies have reported that excessive O2

reacts with NO, which decreases the bioavailability of NO,
thereby impairing endothelial function in spontaneous and
experimental hypertension [26,27,29]. Therefore, one possible
explanation may be attributed to the regulation of O2
– by FA in
endothelial cells in aortic rings from 2K1C rats, although FA
did not affect the SIN-1-induced endothelium-independent
vasodilation. We found in the present study that HHQ, a
generator of O2
 [18], inhibited the FA-induced improvement
in endothelium-dependent vasodilation by acetylcholine in an
O2
-dependent manner in aortic rings with endothelium from
2K1C rats, as had been shown previously in genetically
hypertensive rats [7]. The results imply that HHQ-derived
O2
 most likely interferes with the FA-induced increase in
available NO in endothelial cells in 2K1C hypertensive rats.
In summary, FA was found to restore endothelial function
by altering the basal and stimulated NO bioavailability in
2K1C hypertensive rats. This ﬁnding explains, in part, the
mechanism underlying the vascular effects of FA on blood
pressure in 2K1C chronic renal hypertension.Conﬂict of interest
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